Host: | Rabbit |
Applications: | WB/ELISA |
Reactivity: | Human |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality : | Polyclonal |
Conjugation: | Unconjugated |
Isotype: | IgG |
Formulation: | PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: | Affinity purification |
Concentration: | Lot specific |
Dilution Range: | WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: | TNFRSF8 |
Gene ID: | 943 |
Uniprot ID: | TNR8_HUMAN |
Immunogen Region: | 500-595 |
Specificity: | A synthetic peptide corresponding to a sequence within amino acids 500-595 of human CD30 (NP_001234.3). |
Immunogen Sequence: | LPEPRVSTEHTNNKIEKIYI MKADTVIVGTVKAELPEGRG LAGPAEPELEEELEADHTPH YPEQETEPPLGSCSDVMLSV EEEGKEDPLPTAASGK |
Tissue Specificity | Isoform 2: Detected in alveolar macrophages (at protein level). |
Post Translational Modifications | Phosphorylated on serine and tyrosine residues (Probable). Isoform 2 is constitutively phosphorylated. |
Function | Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B. |
Protein Name | Tumor Necrosis Factor Receptor Superfamily Member 8Cd30l ReceptorKi-1 AntigenLymphocyte Activation Antigen Cd30Cd Antigen Cd30 |
Database Links | Reactome: R-HSA-5669034 |
Cellular Localisation | Isoform 1: Cell MembraneSingle-Pass Type I Membrane ProteinIsoform 2: Cytoplasm |
Alternative Antibody Names | Anti-Tumor Necrosis Factor Receptor Superfamily Member 8 antibodyAnti-Cd30l Receptor antibodyAnti-Ki-1 Antigen antibodyAnti-Lymphocyte Activation Antigen Cd30 antibodyAnti-Cd Antigen Cd30 antibodyAnti-TNFRSF8 antibodyAnti-CD30 antibodyAnti-D1S166E antibody |
Information sourced from Uniprot.org